TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
DCGO

DocGo Inc

Healthcare · Medical Care Facilities

0.3622$ +1.1% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Income Statement

DocGo Inc (DCGO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 73 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement DCGO
Line item Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
13 23 27 31 50 62 86 121 118 110 104 109 113 125 187 199 192 165 139 121 96 80 71 75 76 73 295
9.7 14 18 21 36 41 60 72 78 70 71 66 81 84 132 133 125 109 89 80 65 55 53 51 52 51 206
3.6 8.6 8.7 10 14 21 26 49 40 39 33 42 32 42 55 67 67 56 50 40 31 25 18 24 24 22 89
0.1 0.1 0.3 0.6 0.6 0.7 0.9 1.3 1.1 1.1 1.4 1.7 1.9 2.6 3.2 3.2 2.4 2.4 3.1 3.7 3.6 3.0 3.2 3.8 3.7 3.4 14
8.0 8.8 9.4 13 13 17 20 29 25 28 24 35 33 33 37 47 44 39 32 41 37 36 36 49 36 30 150
9.7 10 11 15 16 21 24 34 30 32 29 42 39 40 46 55 51 46 40 48 45 43 60 57 43 40 200
-6.0 -1.7 -2.6 -4.4 -1.9 0.3 1.5 15 10 7.5 4.2 0.1 -6.9 1.6 8.7 12 16 10 10 -7.5 -14 -17 -42 -32 -19 -18 -111
– 0.0 0.1 0.1 0.1 0.1 0.3 0.3 0.1 0.1 0.3 0.5 809,172 521,872 – 6,979 0.4 0.5 0.5 0.5 0.4 0.4 0.2 0.1 0.1 0.1 0.5
-6.0 -1.7 -2.7 -4.2 -2.0 0.1 1.4 20 9.8 12 2.9 -2.0 -6.0 1.0 9.2 12 16 9.6 9.0 -6.6 -15 -18 -43 -112 -17 -18 -189
0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.4 0.3 0.4 -9.1 -2.1 -0.4 4.5 4.2 5.1 3.7 4.5 1.1 -3.7 -4.6 -14 31 0.0 0.1 17
-6.0 -2.0 -2.4 -4.5 -1.7 -1.6 3.5 24 11 13 3.2 8.1 -3.5 -2.0 4.8 7.6 11 6.5 5.5 -3.3 -9.4 -11 -28 -134 -15 -16 -192
-4.7 -0.4 -1.2 -3.0 -0.3 2.1 3.7 22 12 14 5.9 1.3 -2.4 4.8 13 17 20 14 14 -3.2 -11 -13 -21 -108 -14 -15 -158

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?